Lisa Bero, PhD

Adjunct Professor

Clinical Pharmacology

Lisa A. Bero, PhD, Professor, Department of Clinical Pharmacy, School of Pharmacy and Institute for Health Policy Studies, School of Medicine, University of California, San Francisco, is a pharmacologist with primary interests in how clinical and basic sciences are translated into clinical practice and health policy. She has developed and validated methods for assessing bias in the design, conduct and dissemination of research on pharmaceuticals, tobacco and chemicals. Dr. Bero has also conducted analyses to examine the dissemination and policy implications of research evidence. Her international activities include advisor to the World Health Organization Department of Essential Medicines and Pharmaceutical Policies, member and chair of the WHO Essential Medicines Committee and member of the Pan American Health Organization Advisory Committee on Health Research. She is Director of the San Francisco Branch of the United States Cochrane Center and the World Health Organization Collaborating Centre on Pharmaceutical Research and Science Policy. She was an elected member of the Cochrane Collaboration Steering Group for 12 years and was appointed Co-Chair in 2013. Dr. Bero serves on several national and international committees related to conflicts of interest and research, such as the Institute of Medicine Committee on Conflict of Interest in Medical Research, Education and Practice.

Honors and Awards
  • Harold Luft Award for Mentoring in Health Services and Health Policy Research, Philip R. Lee Institute for Health Policy Studies, UCSF, 2009
  • Distinction in Mentoring Award, UCSF, Academic Senate, 2009
  • LaBelle Lectureship, McMaster University, 1998
Websites
Publications

  1. Parker L, Bero L. Managing risk from conflicts of interest in guideline development committees. BMJ (Clinical research ed.) 2022. PMID: 36593553


  2. Soskolne CL, Kramer S, Ramos-Bonilla JP, Mandrioli D, Sass J, Gochfeld M, Cranor CF, Advani S, Bero LA. Correction: Toolkit for detecting misused epidemiological methods. Environmental health : a global access science source 2022. PMID: 36368967


  3. Soskolne CL, Bero LA, Kramer S, Gochfeld M, Ramos-Bonilla JP, Sass J, Cranor CF, Advani S, Mandrioli D. Response to Toshihide Tsuda, Yumiko Miyano and Eiji Yamamoto [1]. Environmental health : a global access science source 2022. PMID: 36284322


  4. Grundy Q, Huyer LD, Parker L, Bero L. Branded Care: The Policy Implications of Pharmaceutical Industry-Funded Nursing Care Related to Specialty Medicines. Policy, politics & nursing practice 2022. PMID: 36069065


  5. Parker L, Boughton S, Lawrence R, Bero L. Experts identified warning signs of fraudulent research: a qualitative study to inform a screening tool. Journal of clinical epidemiology 2022. PMID: 35850426


  6. Pega F, Momen NC, Bero L, Whaley P. Towards a framework for systematic reviews of the prevalence of exposure to environmental and occupational risk factors. Environmental health : a global access science source 2022. PMID: 35794579


  7. Chiu K, Thow AM, Bero L. The tension between national consistency and jurisdictional professional expansion: The case of pharmacist-administered vaccinations. TO REMOVE 2022. PMID: 35537904


  8. Morrow RL, Mintzes B, Souverein PC, Hallgreen CE, Ahmed B, Roughead EE, De Bruin ML, Kristiansen SB, Lexchin J, Kemp-Casey A, Sketris I, Mangin D, Pearson SA, Puil L, Lopert R, Bero L, Gnjidic D, Sarpatwari A, Dormuth CR. Hydroxyzine Initiation Following Drug Safety Advisories on Cardiac Arrhythmias in the UK and Canada: A Longitudinal Cohort Study. TO REMOVE 2022. PMID: 35438459


  9. Chiu K, Thow AM, Bero L. "Never waste a good crisis": Opportunities and constraints from the COVID-19 pandemic on pharmacists' scope of practice. TO REMOVE 2022. PMID: 35414485


  10. Hilton Boon M, Burns J, Craig P, Griebler U, Heise TL, Vittal Katikireddi S, Rehfuess E, Shepperd S, Thomson H, Bero L. Value and Challenges of Using Observational Studies in Systematic Reviews of Public Health Interventions. TO REMOVE 2022. PMID: 35319925


  11. Pokorny AMJ, Moynihan R, Fox P, Karikios DJ, Bero LA, Mintzes BJ. Australian Cancer Physicians and the Pharmaceutical Industry: A Survey of Attitudes and Interactions. TO REMOVE 2022. PMID: 35316090


  12. Joosse IR, Tordrup D, Bero L, Mantel-Teeuwisse AK, van den Ham HA. A critical review of methodologies used in pharmaceutical pricing policy analyses. TO REMOVE 2022. PMID: 35317924


  13. Pega F, Momen NC, Gagliardi D, Bero LA, Boccuni F, Chartres N, Descatha A, Dzhambov AM, Godderis L, Loney T, Mandrioli D, Modenese A, van der Molen HF, Morgan RL, Neupane S, Pachito D, Paulo MS, Prakash KC, Scheepers PTJ, Teixeira L, Tenkate T, Woodruff TJ, Norris SL. Assessing the quality of evidence in studies estimating prevalence of exposure to occupational risk factors: The QoE-SPEO approach applied in the systematic reviews from the WHO/ILO Joint Estimates of the Work-related burden of disease and Injury. TO REMOVE 2022. PMID: 35182944


  14. Baram L, Dai Z, McDonald S, Bero LA. Disclosure of funding sources and conflicts of interest in evidence underpinning vitamin D and calcium recommendations in bone health guidelines. TO REMOVE 2022. PMID: 35067274


  15. Morrow RL, Mintzes B, Souverein PC, De Bruin ML, Roughead EE, Lexchin J, Kemp-Casey A, Puil L, Sketris I, Mangin D, Hallgreen CE, Pearson SA, Lopert R, Bero L, Ofori-Asenso R, Gnjidic D, Sarpatwari A, Perry LT, Dormuth CR. Influence of drug safety advisories on drug utilisation: an international interrupted time series and meta-analysis. TO REMOVE 2022. PMID: 35058332


  16. Korevaar E, Karahalios A, Turner SL, Forbes AB, Taljaard M, Cheng AC, Grimshaw JM, Bero L, McKenzie JE. Methodological systematic review recommends improvements to conduct and reporting when meta-analysing interrupted time series studies. TO REMOVE 2022. PMID: 35045318


  17. Kanukula R, McKenzie JE, Bero L, Dai Z, McDonald S, Kroeger CM, Korevaar E, Page MJ. Methods used to select results to include in meta-analyses of nutrition research: a meta-research study. TO REMOVE 2021. PMID: 34780979


  18. Langford AV, Gnjidic D, Christine Lin CW, Bero L, Blyth F, Penm J, Schneider CR. "The lesser of two evils": a framework analysis of consumers' perspectives on opioid deprescribing and the development of opioid deprescribing guidelines. TO REMOVE 2021. PMID: 33769364


  19. Pokorny AMJ, Bero LA, Moynihan R, Mintzes BJ. Industry payments to Australian medical oncologists and clinical haematologists: a cross-sectional analysis of publicly-available disclosures. Internal medicine journal 2020. PMID: 32744396


  20. Helfer B, Leonardi-Bee J, Mundell A, Parr C, Ierodiakonou D, Garcia-Larsen V, Kroeger CM, Dai Z, Man A, Jobson J, Dewji F, Kunc M, Bero L, Boyle RJ. Conduct and reporting of formula milk trials: systematic review. TO REMOVE 2021. PMID: 34645600


  21. Mintzes B, Bhasale A, Torka M, Lopert R, Pearson SA, Lexchin J, Bero L. A sorry tale of unnecessary secrecy about medicine safety. TO REMOVE 2021. PMID: 34664366


  22. Pokorny AMJ, Fabbri A, Bero LA, Moynihan R, Mintzes BJ. Interactions with the pharmaceutical industry and the practice, knowledge and beliefs of medical oncologists and clinical haematologists: a systematic review. TO REMOVE 2021. PMID: 34599297


  23. Karanges EA, Nangla C, Parker L, Fabbri A, Farquhar C, Bero L. Pharmaceutical industry payments and assisted reproduction in Australia: a retrospective observational study. TO REMOVE 2021. PMID: 34465582


  24. Soskolne CL, Kramer S, Ramos-Bonilla JP, Mandrioli D, Sass J, Gochfeld M, Cranor CF, Advani S, Bero LA. Toolkit for detecting misused epidemiological methods. TO REMOVE 2021. PMID: 34412643


  25. Diong J, Kroeger CM, Reynolds KJ, Barnett A, Bero LA. Strengthening the incentives for responsible research practices in Australian health and medical research funding. TO REMOVE 2021. PMID: 34340719


  26. Bero L, Lawrence R, Leslie L, Chiu K, McDonald S, Page MJ, Grundy Q, Parker L, Boughton S, Kirkham JJ, Featherstone R. Cross-sectional study of preprints and final journal publications from COVID-19 studies: discrepancies in results reporting and spin in interpretation. TO REMOVE 2021. PMID: 34272226


  27. Dai Z, McKenzie JE, McDonald S, Baram L, Page MJ, Allman-Farinelli M, Raubenheimer D, Bero LA. Assessment of the Methods Used to Develop Vitamin D and Calcium Recommendations-A Systematic Review of Bone Health Guidelines. TO REMOVE 2021. PMID: 34371932


  28. Boughton SL, Wilkinson J, Bero L. When beauty is but skin deep: dealing with problematic studies in systematic reviews. TO REMOVE 2021. PMID: 34081324


  29. Neumann I, Schünemann HJ, Bero L, Cooke G, Magrini N, Moja L. Global access to affordable direct oral anticoagulants. TO REMOVE 2021. PMID: 34475602


  30. Bero LA, Parker L. Risky business? Pharmaceutical industry sponsorship of health consumer groups. TO REMOVE 2021. PMID: 34211242


  31. Fabbri A, Nejstgaard CH, Grundy Q, Bero L, Dunn AG, Mohammad A, Mintzes B. Association Between Conflicts of Interest and Authors' Positions on Harms of Varenicline: a Cross-Sectional Analysis. TO REMOVE 2021. PMID: 34037923


  32. Verbeek J, Hoving J, Boschman J, Chong LY, Livingstone-Banks J, Bero L. Systematic Reviews Should Consider Effects From Both the Population and the Individual Perspective. TO REMOVE 2021. PMID: 33826374


  33. Lexchin J, Bero LA, Davis C, Gagnon MA. Achieving greater independence from commercial influence in research. TO REMOVE 2021. PMID: 33687982


  34. Parker L, Grundy Q, Fabbri A, Mintzes B, Bero L. 'Lines in the sand': an Australian qualitative study of patient group practices to promote independence from pharmaceutical industry funders. TO REMOVE 2021. PMID: 33563626


  35. Nejstgaard CH, Bero L, Hróbjartsson A, Jørgensen AW, Jørgensen KJ, Le M, Lundh A. Association between conflicts of interest and favourable recommendations in clinical guidelines, advisory committee reports, opinion pieces, and narrative reviews: systematic review. TO REMOVE 2020. PMID: 33298430


  36. Nejstgaard CH, Bero L, Hróbjartsson A, Jørgensen AW, Jørgensen KJ, Le M, Lundh A. Conflicts of interest in clinical guidelines, advisory committee reports, opinion pieces, and narrative reviews: associations with recommendations. TO REMOVE 2020. PMID: 33289919


  37. Wang Z, Bero L, Grundy Q. Understanding professional stakeholders' active resistance to guideline implementation: The case of Canadian breast screening guidelines. TO REMOVE 2020. PMID: 33333377


  38. Chartres N, Fabbri A, McDonald S, Diong J, McKenzie JE, Bero L. Association of food industry ties with findings of studies examining the effect of dairy food intake on cardiovascular disease and mortality: systematic review and meta-analysis. TO REMOVE 2020. PMID: 33277278


  39. Parker L, Bennett A, Mintzes B, Grundy Q, Fabbri A, Karanges EA, Bero L. "There are ways … drug companies will get into DTC decisions": How Australian drug and therapeutics committees address pharmaceutical industry influence. TO REMOVE 2020. PMID: 33129226


  40. Wang Z, Grundy Q, Parker L, Bero L. Variations in processes for guideline adaptation: a qualitative study of World Health Organization staff experiences in implementing guidelines. TO REMOVE 2020. PMID: 33228608


  41. Soares-Weiser K, Lasserson T, Jorgensen KJ, Woloshin S, Bero L, Brown MD, Fischhoff B. Policy makers must act on incomplete evidence in responding to COVID-19. TO REMOVE 2020. PMID: 33215686


  42. Bero LA. Improving the Quality of Systematic Reviews in Public Health: Introduction to the Series. TO REMOVE 2020. PMID: 33026865


  43. Anglemyer A, Moore TH, Parker L, Chambers T, Grady A, Chiu K, Parry M, Wilczynska M, Flemyng E, Bero L. Digital contact tracing technologies in epidemics: a rapid review. TO REMOVE 2020. PMID: 33502000


  44. Chartres N, Grundy Q, Parker LM, Bero LA. "It's Not Smooth Sailing": Bridging the Gap Between Methods and Content Expertise in Public Health Guideline Development. International journal of health policy and management 2020. PMID: 32610737


  45. Turner SL, Karahalios A, Forbes AB, Taljaard M, Grimshaw JM, Korevaar E, Cheng AC, Bero L, McKenzie JE. Creating effective interrupted time series graphs: Review and recommendations. Research synthesis methods 2020. PMID: 32657532


  46. Mialon M, Vandevijvere S, Carriedo-Lutzenkirchen A, Bero L, Gomes F, Petticrew M, McKee M, Stuckler D, Sacks G. Mechanisms for addressing and managing the influence of corporations on public health policy, research and practice: a scoping review. BMJ open 2020. PMID: 32690498


  47. Moynihan R, Macdonald H, Bero L, Godlee F. Commercial influence and covid-19. BMJ (Clinical research ed.) 2020. PMID: 32580930


  48. Dai Z, Kroeger CM, Lawrence M, Scrinis G, Bero L. Comparison of methodological quality between the 2007 and 2019 Canadian dietary guidelines. Public health nutrition 2020. PMID: 32552917


  49. Taylor KW, Wang Z, Walker VR, Rooney AA, Bero LA. Using interactive data visualization to facilitate user selection and comparison of risk of bias tools for observational studies of exposures. Environment international 2020. PMID: 32505018


  50. Moynihan R, Albarqouni L, Nangla C, Dunn AG, Lexchin J, Bero L. Financial ties between leaders of influential US professional medical associations and industry: cross sectional study. BMJ (Clinical research ed.) 2020. PMID: 32461201


  51. Bero LA. Producing Independent, Systematic Review Evidence: Cochrane's Response to COVID-19. American journal of public health 2020. PMID: 32407142


  52. Turner K, Carboni-Jiménez A, Benea C, Elder K, Levis B, Boruff J, Roseman M, Bero L, Lexchin J, Turner EH, Benedetti A, Thombs BD. Reporting of drug trial funding sources and author financial conflicts of interest in Cochrane and non-Cochrane meta-analyses: a cross-sectional study. BMJ open 2020. PMID: 32398334


  53. Moynihan R, Fabbri A, Parker L, Bero L. Mixed methods evaluation of workshops for citizen health advocates about financial conflicts of interests in healthcare. BMJ open 2020. PMID: 32393611


  54. Chiu K, McDonald S, Legg T, Karanges EA, Bero L. Policies affecting the supply and access of opioid analgesics: a scoping review protocol. JBI evidence synthesis 2020. PMID: 32813367


  55. Grundy Q, Mazzarello S, Bero L. A comparison of policy provisions for managing "financial" and "non-financial" interests across health-related research organizations: A qualitative content analysis. Accountability in research 2020. PMID: 32233796


  56. Benea C, Turner KA, Roseman M, Bero LA, Lexchin J, Turner EH, Thombs BD. Reporting of financial conflicts of interest in meta-analyses of drug trials published in high-impact medical journals: comparison of results from 2017 to 2018 and 2009. Systematic reviews 2020. PMID: 32268911


  57. Langford AV, Gnjidic D, Lin CC, Bero L, Penm J, Blyth FM, Schneider CR. Challenges of opioid deprescribing and factors to be considered in the development of opioid deprescribing guidelines: a qualitative analysis. BMJ quality & safety 2020. PMID: 32220937


  58. Grundy Q, Dunn AG, Bero L. Improving researchers' conflict of interest declarations. BMJ (Clinical research ed.) 2020. PMID: 32161006


  59. Mandrioli D, Kearns CE, Bero LA. Correction: Relationship between Research Outcomes and Risk of Bias, Study Sponsorship, and Author Financial Conflicts of Interest in Reviews of the Effects of Artificially Sweetened Beverages on Weight Outcomes: A Systematic Review of Reviews. PloS one 2020. PMID: 32155228


  60. Karanges EA, Ting N, Parker L, Fabbri A, Bero L. Pharmaceutical industry payments to leaders of professional medical associations in Australia: Focus on cardiovascular disease and diabetes. Australian journal of general practice 2020. PMID: 32113215


  61. Turner SL, Karahalios A, Forbes AB, Taljaard M, Grimshaw JM, Cheng AC, Bero L, McKenzie JE. Design characteristics and statistical methods used in interrupted time series studies evaluating public health interventions: A review. Journal of clinical epidemiology 2020. PMID: 32109503


  62. Kearns CE, Watt RG, Bero LA, Benzian H. IADR and AADR applaud the Lancet Oral Health Series - Authors' reply. Lancet (London, England) 2020. PMID: 32087791


  63. Korevaar E, Karahalios A, Forbes AB, Turner SL, McDonald S, Taljaard M, Grimshaw JM, Cheng AC, Bero L, McKenzie JE. Methods used to meta-analyse results from interrupted time series studies: A methodological systematic review protocol. TO REMOVE 2020. PMID: 33163155


  64. Ding D, Nguyen B, Gebel K, Bauman A, Bero L. Duplicate and salami publication: a prevalence study of journal policies. International journal of epidemiology 2020. PMID: 32244256


  65. Trevena H, Reeve B, Bero L, Thow AM. Private food safety standards in the global food supply chain: a scoping review protocol. JBI database of systematic reviews and implementation reports 2019. PMID: 31389853


  66. Samet JM, Chiu WA, Cogliano V, Jinot J, Kriebel D, Lunn RM, Beland FA, Bero L, Browne P, Fritschi L, Kanno J, Lachenmeier DW, Lan Q, Lasfargues G, Curieux FL, Peters S, Shubat P, Sone H, White MC, Williamson J, Yakubovskaya M, Siemiatycki J, White PA, Guyton KZ, Schubauer-Berigan MK, Hall AL, Grosse Y, Bouvard V, Benbrahim-Tallaa L, Ghissassi FE, Lauby-Secretan B, Armstrong B, Saracci R, Zavadil J, Straif K, Wild CP. The IARC Monographs: Updated procedures for modern and transparent evidence synthesis in cancer hazard identification. Journal of the National Cancer Institute 2019. PMID: 31498409


  67. Grundy Q, Mayes C, Holloway K, Mazzarello S, Thombs BD, Bero L. Conflict of interest as ethical shorthand: Understanding the range and nature of "non-financial conflict of interest" in biomedicine. Journal of clinical epidemiology 2019. PMID: 31866470


  68. Pega F, Norris SL, Backes C, Bero LA, Descatha A, Gagliardi D, Godderis L, Loney T, Modenese A, Morgan RL, Pachito D, Paulo MBS, Scheepers PTJ, Schlünssen V, Sgargi D, Silbergeld EK, Sørensen K, Sutton P, Tenkate T, Torreão Corrêa da Silva D, Ujita Y, van Deventer E, Woodruff TJ, Mandrioli D. RoB-SPEO: A tool for assessing risk of bias in studies estimating the prevalence of exposure to occupational risk factors from the WHO/ILO Joint Estimates of the Work-related Burden of Disease and Injury. Environment international 2019. PMID: 31864023


  69. Bero L, Chiu K, Grundy Q. The SSSPIN study-spin in studies of spin: meta-research analysis. BMJ (Clinical research ed.) 2019. PMID: 31852680


  70. Parker L, Fabbri A, Grundy Q, Mintzes B, Bero L. "Asset exchange"-interactions between patient groups and pharmaceutical industry: Australian qualitative study. BMJ (Clinical research ed.) 2019. PMID: 31831471


  71. Bero L, Hróbjartsson A, Grundy Q. Response to Soares et al. European journal of clinical nutrition 2019. PMID: 31822820


  72. Johansson M, Bero L, Bonfill X, Bruschettini M, Garner S, Glenton C, Harris R, Jørgensen KJ, Levinson W, Lotfi T, Montori V, Meng DM, Schünemann H, Vaz Carneiro A, Woloshin S, Moynihan R. Cochrane Sustainable Healthcare: evidence for action on too much medicine. The Cochrane database of systematic reviews 2019. PMID: 31808554


  73. Wang Z, Grundy Q, Parker L, Bero L. Health promoter, advocate, legitimiser - the many roles of WHO guidelines: a qualitative study. Health research policy and systems 2019. PMID: 31805956


  74. Moynihan R, Bero L, Hill S, Johansson M, Lexchin J, Macdonald H, Mintzes B, Pearson C, Rodwin MA, Stavdal A, Stegenga J, Thombs BD, Thornton H, Vandvik PO, Wieseler B, Godlee F. Pathways to independence: towards producing and using trustworthy evidence. BMJ (Clinical research ed.) 2019. PMID: 31796508


  75. Grundy Q, Chiu K, Bero L. Commercialization of User Data by Developers of Medicines-Related Apps: a Content Analysis. Journal of general internal medicine 2019. PMID: 31529374


  76. Dai Z, Kroeger CM, McDonald S, Page MJ, McKenzie JE, Allman-Farinelli M, Raubenheimer D, Bero L. Methodological quality of public health guideline recommendations on vitamin D and calcium : a systematic review protocol. BMJ open 2019. PMID: 31699738


  77. Baur X, Soskolne CL, Bero LA. How can the integrity of occupational and environmental health research be maintained in the presence of conflicting interests? Environmental health : a global access science source 2019. PMID: 31684947


  78. Urato AC, Abi-Jaoude E, Abramson J, Alter H, Andrew LB, Antonuccio D, Bero L, Biron P, Boylan LS, Braillon A, Brophy JM, Brownlee S, Cassels A, Cook-Deegan R, Cosgrove L, De Fiore L, Deyo RA, Elshaug A, Farquhar C, Fatovich DM, Fingerman E, Gérvas J, Gøtzsche PC, Gracia R, Heath I, Himmelstein DU, Hoffman JR, Järvinen T, Jureidini J, Kotaska A, Kuehlein T, Lenzer J, Levenstein S, Lexchin J, Mintzes B, Naudet F, Niquette M, Orellana Navarrete LP, Pearson CA, Rail G, Roberts R, Shah N, Sharav V, Siwek J, Topolski S, Tsai AC. National Partnership for Maternal Safety: Consensus Bundle on Venous Thromboembolism. Obstetrics and gynecology 2019. PMID: 31651818


  79. Page MJ, Bero L, Kroeger CM, Dai Z, McDonald S, Forbes A, McKenzie JE. Investigation of Risk Of Bias due to Unreported and SelecTively included results in meta-analyses of nutrition research: the ROBUST study protocol. F1000Research 2019. PMID: 32117567


  80. Karanges EA, Grundy Q, Bero L. Understanding the Nature and Extent of Pharmaceutical Industry Payments to Nonphysician Clinicians. JAMA internal medicine 2019. PMID: 31180446


  81. McDonald S, Fabbri A, Parker L, Williams J, Bero L. Medical donations are not always free: an assessment of compliance of medicine and medical device donations with World Health Organization guidelines (2009-2017). International health 2019. PMID: 30916303


  82. Behdarvand B, Karanges EA, Bero L. Pharmaceutical industry funding of events for healthcare professionals on non-vitamin K oral anticoagulants in Australia: an observational study. BMJ open 2019. PMID: 31434780


  83. Kearns CE, Bero LA. Conflicts of interest between the sugary food and beverage industry and dental research organisations: time for reform. Lancet (London, England) 2019. PMID: 31327353


  84. Soskolne CL, Advani S, Sass J, Bero LA, Ruff K. Response to Acquavella J, conflict of interest: a hazard for epidemiology. Annals of epidemiology 2019. PMID: 31401133


  85. Chartres N, Fabbri A, McDonald S, Turton J, Allman-Farinelli M, McKenzie J, Bero L. Association of industry ties with outcomes of studies examining the effect of wholegrain foods on cardiovascular disease and mortality: systematic review and meta-analysis. BMJ open 2019. PMID: 31110080


  86. Moynihan R, Macdonald H, Heneghan C, Bero L, Godlee F. Commercial interests, transparency, and independence: a call for submissions. BMJ (Clinical research ed.) 2019. PMID: 30992258


  87. Bero LA, Norris SL, Lawrence MA. Making nutrition guidelines fit for purpose. BMJ (Clinical research ed.) 2019. PMID: 30992263


  88. Grundy Q, Chiu K, Held F, Continella A, Bero L, Holz R. Data sharing practices of medicines related apps and the mobile ecosystem: traffic, content, and network analysis. BMJ (Clinical research ed.) 2019. PMID: 30894349


  89. Parker L, Bero L, Gillies D, Raven M, Grundy Q. The "Hot Potato" of Mental Health App Regulation: A Critical Case Study of the Australian Policy Arena. International journal of health policy and management 2018. PMID: 30980633


  90. Parker L, Karanges EA, Bero L. Changes in the type and amount of spending disclosed by Australian pharmaceutical companies: an observational study. BMJ open 2019. PMID: 30782921


  91. Moynihan R, Lai A, Jarvis H, Duggan G, Goodrick S, Beller E, Bero L. Undisclosed financial ties between guideline writers and pharmaceutical companies: a cross-sectional study across 10 disease categories. BMJ open 2019. PMID: 30813119


  92. Turner SL, Karahalios A, Forbes AB, Taljaard M, Grimshaw JM, Cheng AC, Bero L, McKenzie JE. Design characteristics and statistical methods used in interrupted time series studies evaluating public health interventions: protocol for a review. BMJ open 2019. PMID: 30696676


  93. Bero L, Chartres N, Diong J, Fabbri A, Ghersi D, Lam J, Lau A, McDonald S, Mintzes B, Sutton P, Turton JL, Woodruff TJ. The risk of bias in observational studies of exposures (ROBINS-E) tool: concerns arising from application to observational studies of exposures. Systematic reviews 2018. PMID: 30577874


  94. Chartres N, Bero LA, Norris SL. A review of methods used for hazard identification and risk assessment of environmental hazards. Environment international 2018. PMID: 30537638


  95. Rasmussen K, Bero L, Redberg R, Gøtzsche PC, Lundh A. Collaboration between academics and industry in clinical trials: cross sectional study of publications and survey of lead academic authors. BMJ (Clinical research ed.) 2018. PMID: 30282703


  96. Fabbri A, Lai A, Grundy Q, Bero LA. The Influence of Industry Sponsorship on the Research Agenda: A Scoping Review. American journal of public health 2018. PMID: 30252531


  97. van der Eijk Y, Bero LA, Malone RE. Philip Morris International-funded 'Foundation for a Smoke-Free World': analysing its claims of independence. Tobacco control 2018. PMID: 30242044


  98. Fabbri A, Holland TJ, Bero LA. Food industry sponsorship of academic research: investigating commercial bias in the research agenda. Public health nutrition 2018. PMID: 30157979


  99. Lundh A, Lexchin J, Mintzes B, Schroll JB, Bero L. Industry sponsorship and research outcome: systematic review with meta-analysis. Intensive care medicine 2018. PMID: 30132025


  100. Bero L, Grundy Q. Conflicts of Interest in Nutrition Research. JAMA 2018. PMID: 29971390


  101. Parker L, Bero L, Gillies D, Raven M, Mintzes B, Jureidini J, Grundy Q. Mental Health Messages in Prominent Mental Health Apps. Annals of family medicine 2018. PMID: 29987082


  102. Bero L. Ten tips for spotting industry involvement in science policy. Tobacco control 2018. PMID: 29941543


  103. Rezende LFM, Rey-López JP, Sá TH, Chartres N, Fabbri A, Powell L, Stamatakis E, Bero L. Reporting bias in the literature on the associations of health-related behaviors and statins with cardiovascular disease and all-cause mortality. PLoS biology 2018. PMID: 29912869


  104. Parker L, Grundy Q, Bero L. Interpreting evidence in general practice: Bias and conflicts of interest. Australian journal of general practice 2018. PMID: 29966180


  105. Wang Z, Norris SL, Bero L. The advantages and limitations of guideline adaptation frameworks. Implementation science : IS 2018. PMID: 29843737


  106. Bero LA, Grundy Q. Not All Influences on Science Are Conflicts of Interest. American journal of public health 2018. PMID: 29617619


  107. Parker L, Williams J, Bero L. Ethical drug marketing criteria for the 21st century. BMJ (Clinical research ed.) 2018. PMID: 29712644


  108. Bero L. Meta-research matters: Meta-spin cycles, the blindness of bias, and rebuilding trust. PLoS biology 2018. PMID: 29608562


  109. Blake P, Durão S, Naude CE, Bero L. An analysis of methods used to synthesize evidence and grade recommendations in food-based dietary guidelines. Nutrition reviews 2018. PMID: 29425371


  110. Mintzes B, Swandari S, Fabbri A, Grundy Q, Moynihan R, Bero L. Does industry-sponsored education foster overdiagnosis and overtreatment of depression, osteoporosis and over-active bladder syndrome? An Australian cohort study. BMJ open 2018. PMID: 29440213


  111. Mahmic-Kaknjo M, Jelicic-Kadic A, Utrobicic A, Chan K, Bero L, Marušic A. Essential medicines availability is still suboptimal in many countries: a scoping review. Journal of clinical epidemiology 2018. PMID: 29452222


  112. Grundy Q, Dunn AG, Bourgeois FT, Coiera E, Bero L. Prevalence of Disclosed Conflicts of Interest in Biomedical Research and Associations With Journal Impact Factors and Altmetric Scores. JAMA 2018. PMID: 29362787


  113. Bero L. Getting the systematic review basics right helps clinical practice: 4 common pitfalls for systematic review authors to avoid. British journal of sports medicine 2017. PMID: 29217534


  114. Bero L. Developing reliable dietary guidelines. BMJ (Clinical research ed.) 2017. PMID: 29101096


  115. Grundy Q, Held F, Bero L. A Social Network Analysis of the Financial Links Backing Health and Fitness Apps. American journal of public health 2017. PMID: 28933939


  116. Chiu K, Grundy Q, Bero L. 'Spin' in published biomedical literature: A methodological systematic review. PLoS biology 2017. PMID: 28892482


  117. Fabbri A, Chartres N, Bero LA. Study sponsorship and the nutrition research agenda: analysis of cohort studies examining the association between nutrition and obesity. Public health nutrition 2017. PMID: 28851466


  118. Fabbri A, Grundy Q, Mintzes B, Swandari S, Moynihan R, Walkom E, Bero LA. A cross-sectional analysis of pharmaceutical industry-funded events for health professionals in Australia. BMJ open 2017. PMID: 28667226


  119. Grundy Q, Held FP, Bero LA. Tracing the Potential Flow of Consumer Data: A Network Analysis of Prominent Health and Fitness Apps. Journal of medical Internet research 2017. PMID: 28659254


  120. Walker J, Chaar BB, Vera N, Pillai AS, Lim JS, Bero L, Moles RJ. Medicine shortages in Fiji: A qualitative exploration of stakeholders' views. PloS one 2017. PMID: 28582409


  121. Cosgrove L, Shaughnessy AF, Peters SM, Lexchin JR, Bursztajn H, Bero L. Conflicts of Interest and the Presence of Methodologists on Guideline Development Panels: A Cross-Sectional Study of Clinical Practice Guidelines for Major Depressive Disorder. Psychotherapy and psychosomatics 2017. PMID: 28490018


  122. Bero L. Addressing Bias and Conflict of Interest Among Biomedical Researchers. JAMA 2017. PMID: 28464166


  123. Moynihan R, Bero L. Toward a Healthier Patient Voice: More Independence, Less Industry Funding. JAMA internal medicine 2017. PMID: 28114596


  124. Apollonio DE, Bero LA. Interpretation and use of evidence in state policymaking: a qualitative analysis. BMJ open 2017. PMID: 28219958


  125. Lundh A, Lexchin J, Mintzes B, Schroll JB, Bero L. Industry sponsorship and research outcome. The Cochrane database of systematic reviews 2017. PMID: 28207928


  126. Lundh A, Bero L. The ties that bind. BMJ (Clinical research ed.) 2017. PMID: 28096082


  127. Bero LA, Grundy Q. Why Having a (Nonfinancial) Interest Is Not a Conflict of Interest. PLoS biology 2016. PMID: 28002462


  128. Fabbri A, Chartres N, Scrinis G, Bero LA. Study sponsorship and the nutrition research agenda: analysis of randomized controlled trials included in systematic reviews of nutrition interventions to address obesity. Public health nutrition 2016. PMID: 27989264


  129. Chartres N, Fabbri A, Bero LA. Association of Industry Sponsorship With Outcomes of Nutrition Studies: A Systematic Review and Meta-analysis. JAMA internal medicine 2016. PMID: 27802480


  130. Apollonio D, Philipps R, Bero L. Interventions for tobacco use cessation in people in treatment for or recovery from substance use disorders. The Cochrane database of systematic reviews 2016. PMID: 27878808


  131. Lawrence M, Naude C, Armstrong R, Bero L, Covic N, Durao S, Ghersi D, Macdonald G, MacLehose H, Margetts B, Tovey D, Volmink J, Young T. A call to action to reshape evidence synthesis and use for nutrition policy. The Cochrane database of systematic reviews 2016. PMID: 27883192


  132. Bero L. Systematic Review: A Method at Risk for Being Corrupted. American journal of public health 2016. PMID: 27854519


  133. Grundy Q, Fabbri A, Mintzes B, Swandari S, Bero L. The Inclusion of Nurses in Pharmaceutical Industry-Sponsored Events: Guess Who Is Also Coming to Dinner? JAMA internal medicine 2016. PMID: 27617386


  134. Norris SL, Bero L. GRADE Methods for Guideline Development: Time to Evolve? Annals of internal medicine 2016. PMID: 27654340


  135. Grundy QH, Wang Z, Bero LA. Challenges in Assessing Mobile Health App Quality: A Systematic Review of Prevalent and Innovative Methods. American journal of preventive medicine 2016. PMID: 27659122


  136. Mandrioli D, Kearns CE, Bero LA. Relationship between Research Outcomes and Risk of Bias, Study Sponsorship, and Author Financial Conflicts of Interest in Reviews of the Effects of Artificially Sweetened Beverages on Weight Outcomes: A Systematic Review of Reviews. PloS one 2016. PMID: 27606602


  137. Apollonio DE, Wolfe N, Bero LA. Realist review of policy intervention studies aimed at reducing exposures to environmental hazards in the United States. BMC public health 2016. PMID: 27539238


  138. Vandenberg LN, Ågerstrand M, Beronius A, Beausoleil C, Bergman Å, Bero LA, Bornehag CG, Boyer CS, Cooper GS, Cotgreave I, Gee D, Grandjean P, Guyton KZ, Hass U, Heindel JJ, Jobling S, Kidd KA, Kortenkamp A, Macleod MR, Martin OV, Norinder U, Scheringer M, Thayer KA, Toppari J, Whaley P, Woodruff TJ, Rudén C. A proposed framework for the systematic review and integrated assessment (SYRINA) of endocrine disrupting chemicals. Environmental health : a global access science source 2016. PMID: 27412149


  139. Apollonio DE, Bero LA. Challenges to generating evidence-informed policy and the role of systematic reviews and (perceived) conflicts of interest. Journal of Communication In Healthcare 2016. PMID: 27721899


  140. Wang Z, Norris SL, Bero L. Implementation plans included in World Health Organisation guidelines. Implementation science : IS 2016. PMID: 27207104


  141. Johnson PI, Koustas E, Vesterinen HM, Sutton P, Atchley DS, Kim AN, Campbell M, Donald JM, Sen S, Bero L, Zeise L, Woodruff TJ. Application of the Navigation Guide systematic review methodology to the evidence for developmental and reproductive toxicity of triclosan. Environment international 2016. PMID: 27156197


  142. Grundy Q, Bero LA, Malone RE. Marketing and the Most Trusted Profession: The Invisible Interactions Between Registered Nurses and Industry. Annals of internal medicine 2016. PMID: 27043976


  143. Morgan RL, Thayer KA, Bero L, Bruce N, Falck-Ytter Y, Ghersi D, Guyatt G, Hooijmans C, Langendam M, Mandrioli D, Mustafa RA, Rehfuess EA, Rooney AA, Shea B, Silbergeld EK, Sutton P, Wolfe MS, Woodruff TJ, Verbeek JH, Holloway AC, Santesso N, Schünemann HJ. GRADE: Assessing the quality of evidence in environmental and occupational health. Environment international 2016. PMID: 26827182


  144. Bero L, Anglemyer A, Vesterinen H, Krauth D. The relationship between study sponsorship, risks of bias, and research outcomes in atrazine exposure studies conducted in non-human animals: Systematic review and meta-analysis. Environment international 2015. PMID: 26694022


  145. Tuller D, Bero L. Big Tobacco and Drugstore Chains: A Long, Cozy Relationship. JAMA oncology 2015. PMID: 26355634


  146. Elliott JH, Grimshaw J, Altman R, Bero L, Goodman SN, Henry D, Macleod M, Tovey D, Tugwell P, White H, Sim I. Informatics: Make sense of health data. Volume 527 of Issue 7576. Nature 2015. PMID: 26536942


  147. Alexander PE, Gionfriddo MR, Li SA, Bero L, Stoltzfus RJ, Neumann I, Brito JP, Djulbegovic B, Montori VM, Norris SL, Schünemann HJ, Thabane L, Guyatt GH. A number of factors explain why WHO guideline developers make strong recommendations inconsistent with GRADE guidance. Journal of clinical epidemiology 2015. PMID: 26399903


  148. Chang L, Dhruva SS, Chu J, Bero LA, Redberg RF. Selective reporting in trials of high risk cardiovascular devices: cross sectional comparison between premarket approval summaries and published reports. Volume 350. BMJ (Clinical research ed.) 2015. PMID: 26063311


  149. Tran DN, Bero LA. Barriers and facilitators to the quality use of essential medicines for maternal health in low-resource countries: An Ishikawa framework. Journal of global health 2015. PMID: 25969730


  150. Moynihan R, Nickel B, Hersch J, Beller E, Doust J, Compton S, Barratt A, Bero L, McCaffery K. Public Opinions about Overdiagnosis: A National Community Survey. PloS one 2015. PMID: 25992887


  151. Schroll J, Bero L. Regulatory agencies hold the key to improving Cochrane reviews of drugs. The Cochrane database of systematic reviews 2015. PMID: 25904511


  152. Siler K, Lee K, Bero L. Reply to Margalida and Colomer: Science should strive to prevent mistakes, not corrections. Proceedings of the National Academy of Sciences of the United States of America 2015. PMID: 25759436


  153. Anglemyer AT, Krauth D, Bero L. Industry sponsorship and publication bias among animal studies evaluating the effects of statins on atherosclerosis and bone outcomes: a meta-analysis. BMC medical research methodology 2015. PMID: 25880564


  154. Chiu Y, Bero L, Hessol NA, Lexchin J, Harrington C. A literature review of clinical outcomes associated with antipsychotic medication use in North American nursing home residents. Health policy (Amsterdam, Netherlands) 2015. PMID: 25791166


  155. Hill SR, Bero L, McColl G, Roughead E. Expensive medicines: ensuring objective appraisal and equitable access. Bulletin of the World Health Organization 2015. PMID: 25558099


  156. Siler K, Lee K, Bero L. Measuring the effectiveness of scientific gatekeeping. Proceedings of the National Academy of Sciences of the United States of America 2014. PMID: 25535380


  157. Alexander PE, Brito JP, Neumann I, Gionfriddo MR, Bero L, Djulbegovic B, Stoltzfus R, Montori VM, Norris SL, Schünemann HJ, Guyatt GH. World Health Organization strong recommendations based on low-quality evidence (study quality) are frequent and often inconsistent with GRADE guidance. Journal of clinical epidemiology 2014. PMID: 25618534


  158. Forsyth SR, Odierna DH, Krauth D, Bero LA. Conflicts of interest and critiques of the use of systematic reviews in policymaking: an analysis of opinion articles. Systematic reviews 2014. PMID: 25417178


  159. Bero L. Bias related to funding source in statin trials. BMJ (Clinical research ed.) 2014. PMID: 25281682


  160. Fox DM, Bero L. Systematic reviews: perhaps "the answer to policy makers' prayers"? Environmental health perspectives 2014. PMID: 25272205


  161. Magrini N, Robertson J, de Joncheere K, Bero L. On WHO's essential medicines process and transparency. BMJ (Clinical research ed.) 2014. PMID: 25231094


  162. Formoso G, Marata AM, Magrini N, Bero L. A clearer view of evidence in treating macular degeneration: off-label policies and independent research. The Cochrane database of systematic reviews 2014. PMID: 25228121


  163. Schroll JB, Abdel-Sattar M, Bero L. The Food and Drug Administration reports provided more data but were more difficult to use than the European Medicines Agency reports. Journal of clinical epidemiology 2014. PMID: 25150193


  164. Bero L. What is in a name? Nonfinancial influences on the outcomes of systematic reviews and guidelines. Journal of clinical epidemiology 2014. PMID: 25132356


  165. Mahady SE, Schlub T, Bero L, Moher D, Tovey D, George J, Craig JC. Side effects are incompletely reported among systematic reviews in gastroenterology. Journal of clinical epidemiology 2014. PMID: 25124168


  166. Tovey D, Churchill R, Bero L. Evidence based medicine: looking forward and building on what we have learnt. BMJ (Clinical research ed.) 2014. PMID: 25008476


  167. Anglemyer A, Horvath HT, Bero L. Healthcare outcomes assessed with observational study designs compared with those assessed in randomized trials. The Cochrane database of systematic reviews 2014. PMID: 24782322


  168. Abdel-Sattar M, Krauth D, Anglemyer A, Bero L. The Relationship between Risk of Bias Criteria, Research Outcomes, and Study Sponsorship in a Cohort of Preclinical Thiazolidinedione Animal Studies: A Meta-Analysis. Evidence-based preclinical medicine 2014. PMID: 25642330


  169. Krauth D, Woodruff TJ, Bero L. Instruments for assessing risk of bias and other methodological criteria: Krauth et al. Respond. Environmental health perspectives 2014. PMID: 24583480


  170. Coralic Z, Kanzaria HK, Bero L, Stein J. Staff perceptions of an on-site clinical pharmacist program in an academic emergency department after one year. The western journal of emergency medicine 2014. PMID: 24672613


  171. Krauth D, Anglemyer A, Philipps R, Bero L. Nonindustry-sponsored preclinical studies on statins yield greater efficacy estimates than industry-sponsored studies: a meta-analysis. PLoS biology 2014. PMID: 24465178


  172. Alexander PE, Bero L, Montori VM, Brito JP, Stoltzfus R, Djulbegovic B, Neumann I, Rave S, Guyatt G. World Health Organization recommendations are often strong based on low confidence in effect estimates. Journal of clinical epidemiology 2014. PMID: 24388966


  173. Odierna DH, Bero LA. Retaining Participants in Outpatient and Community-Based Health Studies: Researchers and Participants in Their Own Words. SAGE open 2014. PMID: 25599003


  174. Bero LA. Why the Cochrane risk of bias tool should include funding source as a standard item. The Cochrane database of systematic reviews 2013. PMID: 24575439


  175. Chahal HS, St Fort N, Bero L. Availability, prices and affordability of essential medicines in Haiti. Journal of global health 2013. PMID: 24363923


  176. Neltner TG, Alger HM, O'Reilly JT, Krimsky S, Bero LA, Maffini MV. Conflicts of interest in approvals of additives to food determined to be generally recognized as safe: out of balance. JAMA internal medicine 2013. PMID: 23925593


  177. Grundy Q, Bero L, Malone R. Interactions between non-physician clinicians and industry: a systematic review. PLoS medicine 2013. PMID: 24302892


  178. Apollonio DE, Glantz SA, Bero LA. Term limits and the tobacco industry. Volume 104. Social science & medicine (1982) 2013. PMID: 24581055


  179. Moynihan RN, Cooke GP, Doust JA, Bero L, Hill S, Glasziou PP. Expanding disease definitions in guidelines and expert panel ties to industry: a cross-sectional study of common conditions in the United States. PLoS medicine 2013. PMID: 23966841


  180. Krauth D, Woodruff TJ, Bero L. Instruments for assessing risk of bias and other methodological criteria of published animal studies: a systematic review. Environmental health perspectives 2013. PMID: 23771496


  181. Wolfe N, Gøtzsche PC, Bero L. Strategies for obtaining unpublished drug trial data: a qualitative interview study. Systematic reviews 2013. PMID: 23680054


  182. Schroll JB, Bero L, Gøtzsche PC. Searching for unpublished data for Cochrane reviews: cross sectional study. BMJ (Clinical research ed.) 2013. PMID: 23613540


  183. Bero L. Industry sponsorship and research outcome: a Cochrane review. JAMA internal medicine 2013. PMID: 23440226


  184. Nguyen NY, Bero L. Medicaid drug selection committees and inadequate management of conflicts of interest. JAMA internal medicine 2013. PMID: 23400249


  185. Conway J, Bero L, Ondari C, Wasan KM. Review of the quality of pediatric medications in developing countries. Journal of pharmaceutical sciences 2013. PMID: 23450511


  186. Pande S, Hiller JE, Nkansah N, Bero L. The effect of pharmacist-provided non-dispensing services on patient outcomes, health service utilisation and costs in low- and middle-income countries. The Cochrane database of systematic reviews 2013. PMID: 23450614


  187. Odierna DH, Forsyth SR, White J, Bero LA. The cycle of bias in health research: a framework and toolbox for critical appraisal training. Accountability in research 2013. PMID: 23432773


  188. Odierna DH, White J, Forsyth S, Bero LA. Critical appraisal training increases understanding and confidence and enhances the use of evidence in diverse categories of learners. Health expectations : an international journal of public participation in health care and health policy 2012. PMID: 23252397


  189. Taba P, Rosenthal M, Habicht J, Tarien H, Mathiesen M, Hill S, Bero L. Barriers and facilitators to the implementation of clinical practice guidelines: a cross-sectional survey among physicians in Estonia. BMC health services research 2012. PMID: 23234504


  190. Lundh A, Sismondo S, Lexchin J, Busuioc OA, Bero L. Industry sponsorship and research outcome. The Cochrane database of systematic reviews 2012. PMID: 23235689


  191. Apollonio D, Philipps R, Bero L. Interventions for tobacco use cessation in people in treatment for or recovery from substance abuse. The Cochrane library 2012. PMID: 23833567


  192. Bero L, Busuttil G, Farquhar C, Koehlmoos TP, Moher D, Nylenna M, Smith R, Tovey D. Measuring the performance of the Cochrane library. The Cochrane database of systematic reviews 2012. PMID: 23235688


  193. Bero LA, Hill S, Habicht J, Mathiesen M, Starkopf J. The updated clinical guideline development process in Estonia is an efficient method for developing evidence-based guidelines. Journal of clinical epidemiology 2012. PMID: 22974497


  194. Bero LA, Binder L. The Cochrane Collaboration review prioritization projects show that a variety of approaches successfully identify high-priority topics. Journal of clinical epidemiology 2012. PMID: 22959591


  195. Roseman M, Turner EH, Lexchin J, Coyne JC, Bero LA, Thombs BD. Reporting of conflicts of interest from drug trials in Cochrane reviews: cross sectional study. BMJ (Clinical research ed.) 2012. PMID: 22906823


  196. Anson A, Ramay B, de Esparza AR, Bero L. Availability, prices and affordability of the World Health Organization's essential medicines for children in Guatemala. Globalization and health 2012. PMID: 22747646


  197. Hill S, Yang A, Bero L. Priority medicines for maternal and child health: a global survey of national essential medicines lists. PloS one 2012. PMID: 22675435


  198. Norris SL, Burda BU, Holmer HK, Ogden LA, Fu R, Bero L, Schünemann H, Deyo R. Author's specialty and conflicts of interest contribute to conflicting guidelines for screening mammography. Journal of clinical epidemiology 2012. PMID: 22498428


  199. Malone RE, Grundy Q, Bero LA. Tobacco industry denormalisation as a tobacco control intervention: a review. Tobacco control 2012. PMID: 22345240


  200. Hart B, Lundh A, Bero L. Effect of reporting bias on meta-analyses of drug trials: reanalysis of meta-analyses. BMJ (Clinical research ed.) 2012. PMID: 22214754


  201. Sutton P, Woodruff TJ, Vogel S, Bero LA. Conrad and Becker's "10 Criteria" fall short of addressing conflicts of interest in chemical safety studies. Environmental health perspectives 2011. PMID: 22134036


  202. Walleser S, Hill SR, Bero LA. Characteristics and quality of reporting of cluster randomized trials in children: reporting needs improvement. Journal of clinical epidemiology 2011. PMID: 21775103


  203. Krleža-Jeriç K, Lemmens T, Reveiz L, Cuervo LG, Bero LA. Prospective registration and results disclosure of clinical trials in the Americas: a roadmap toward transparency. Revista panamericana de salud publica = Pan American journal of public health 2011. PMID: 22159656


  204. Millar TP, Wong S, Odierna DH, Bero LA. Applying the essential medicines concept to US preferred drug lists. American journal of public health 2011. PMID: 21680927


  205. Roseman M, Milette K, Bero LA, Coyne JC, Lexchin J, Turner EH, Thombs BD. Reporting of conflicts of interest in meta-analyses of trials of pharmacological treatments. JAMA 2011. PMID: 21386079


  206. Dhruva SS, Bero LA, Redberg RF. Gender bias in studies for Food and Drug Administration premarket approval of cardiovascular devices. Volume 4 of Issue 2. Circulation. Cardiovascular quality and outcomes 2011. PMID: 21364127


  207. Bero LA, Ghersi D. Making systematic reviews global. The Cochrane database of systematic reviews 2011. PMID: 21833979


  208. Smith R, Tovey D, Bero L, Busuttil G, Farquhar C, Koehlmoos TP, Moher D, Nylenna M, Pais P. The Cochrane Library Oversight Committee. The Cochrane database of systematic reviews 2011. PMID: 21833980


  209. Ridge AL, Bero LA, Hill SR. Identifying barriers to the availability and use of Magnesium Sulphate Injection in resource poor countries: a case study in Zambia. BMC health services research 2010. PMID: 21162717


  210. Chen CE, Dhruva SS, Bero LA, Redberg RF. Inclusion of training patients in US Food and Drug Administration premarket approval cardiovascular device studies. Volume 171 of Issue 6. Archives of internal medicine 2010. PMID: 21098342


  211. Bero L, Carson B, Moller H, Hill S. To give is better than to receive: compliance with WHO guidelines for drug donations during 2000-2008. Bulletin of the World Health Organization 2010. PMID: 21124717


  212. Cataldo JK, Bero LA, Malone RE. "A delicate diplomatic situation": tobacco industry efforts to gain control of the Framingham Study. Journal of clinical epidemiology 2010. PMID: 20630333


  213. Saint-Raymond A, Hill S, Martines J, Bahl R, Fontaine O, Bero L. CONSORT 2010. Lancet (London, England) 2010. PMID: 20656114


  214. Nkansah N, Mostovetsky O, Yu C, Chheng T, Beney J, Bond CM, Bero L. Effect of outpatient pharmacists' non-dispensing roles on patient outcomes and prescribing patterns. The Cochrane database of systematic reviews 2010. PMID: 20614422


  215. Robertson J, Walkom E, Moynihan R, Bero L, Henry D. Pharmaceutical industry funding of educational events for pharmacists in Australia: an analysis of data from the first 6 months of a mandatory disclosure programme. The International journal of pharmacy practice 2010. PMID: 20441117


  216. Montini T, George A, Martin-Mollard M, Bero LA. The role of public participation in public health initiatives: an analysis of the WHO Framework Convention on Tobacco Control. Global public health 2010. PMID: 19326277


  217. Dhruva SS, Bero LA, Redberg RF. Strength of study evidence examined by the FDA in premarket approval of cardiovascular devices. Volume 302 of Issue 24. JAMA 2009. PMID: 20040556


  218. Rasmussen N, Lee K, Bero L. Association of trial registration with the results and conclusions of published trials of new oncology drugs. Trials 2009. PMID: 20015404


  219. Vedula SS, Bero L, Scherer RW, Dickersin K. Outcome reporting in industry-sponsored trials of gabapentin for off-label use. The New England journal of medicine 2009. PMID: 19907043


  220. Robertson J, Moynihan R, Walkom E, Bero L, Henry D. Mandatory disclosure of pharmaceutical industry-funded events for health professionals. PLoS medicine 2009. PMID: 19885393


  221. Cook DM, Bero LA. The politics of smoking in federal buildings: an executive order case study. American journal of public health 2009. PMID: 19608948


  222. Apollonio DE, Bero LA. Evidence and argument in policymaking: development of workplace smoking legislation. BMC public health 2009. PMID: 19534777


  223. Rattinger G, Bero L. Factors associated with results and conclusions of trials of thiazolidinediones. PloS one 2009. PMID: 19503811


  224. Odierna DH, Bero LA. Systematic reviews reveal unrepresentative evidence for the development of drug formularies for poor and nonwhite populations. Journal of clinical epidemiology 2009. PMID: 19375890


  225. Nkansah N, Nguyen T, Iraninezhad H, Bero L. Randomized trials assessing calcium supplementation in healthy children: relationship between industry sponsorship and study outcomes. Public health nutrition 2009. PMID: 19254426


  226. Kummerfeldt CE, Barnoya J, Bero L. Philip Morris involvement in the development of an air quality laboratory in El Salvador. Tobacco control 2009. PMID: 19211614


  227. White J, Bandura A, Bero LA. Moral disengagement in the corporate world. Accountability in research 2009. PMID: 19247852


  228. Cook DM, Gurugubelli RK, Bero LA. Risk management policy and black-box warnings: a qualitative analysis of US FDA proceedings. Drug safety 2009. PMID: 19810777


  229. Montini T, Bero LA. Implementation of a workplace smoking ban in bars: the limits of local discretion. BMC public health 2008. PMID: 19063716


  230. Rising K, Bacchetti P, Bero L. Reporting bias in drug trials submitted to the Food and Drug Administration: review of publication and presentation. PLoS medicine 2008. PMID: 19067477


  231. Bero L. "Experimental" institutional models for corporate funding of academic research: unknown effects on the research enterprise. Journal of clinical epidemiology 2008. PMID: 18538259


  232. Jewell CJ, Bero LA. "Developing good taste in evidence": facilitators of and hindrances to evidence-informed health policymaking in state government. The Milbank quarterly 2008. PMID: 18522611


  233. Finley PR, Bero L. Clarification of study and citation. Archives of internal medicine 2007. PMID: 18071185


  234. Cook DM, Boyd EA, Grossmann C, Bero LA. Reporting science and conflicts of interest in the lay press. PloS one 2007. PMID: 18060060


  235. Yank V, Rennie D, Bero LA. Financial ties and concordance between results and conclusions in meta-analyses: retrospective cohort study. BMJ (Clinical research ed.) 2007. PMID: 18024482


  236. Boyd EA, Bero LA. Defining financial conflicts and managing research relationships: an analysis of university conflict of interest committee decisions. Science and engineering ethics 2007. PMID: 18008185


  237. Prochaska JJ, Hall SM, Bero LA. Tobacco use among individuals with schizophrenia: what role has the tobacco industry played? Schizophrenia bulletin 2007. PMID: 17984298


  238. White J, Parascandola M, Bero L. Tobacco industry research and protection of human subjects: a case study of R. J. Reynolds. Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco 2007. PMID: 17978997


  239. Apollonio DE, Lopipero P, Bero LA. Participation and argument in legislative debate on statewide smoking restrictions. Health research policy and systems 2007. PMID: 17953767


  240. Schick SF, Bero LA, Cook DM. The tobacco industry and the Data Quality Act. Science (New York, N.Y.) 2007. PMID: 17702925


  241. Freemantle N, Harvey EL, Wolf F, Grimshaw JM, Grilli R, Bero LA. WITHDRAWN: Printed educational materials: effects on professional practice and health care outcomes. The Cochrane database of systematic reviews 2007. PMID: 17636612


  242. Bero L. [Shall we ban industrial funds for research?]. Epidemiologia e prevenzione 2007. PMID: 18019196


  243. Bero L, Oostvogel F, Bacchetti P, Lee K. Factors associated with findings of published trials of drug-drug comparisons: why some statins appear more efficacious than others. PLoS medicine 2007. PMID: 17550302


  244. Steinman MA, Harper GM, Chren MM, Landefeld CS, Bero LA. Characteristics and impact of drug detailing for gabapentin. PLoS medicine 2007. PMID: 17455990


  245. Apollonio DE, Bero LA. The creation of industry front groups: the tobacco industry and "get government off our back". American journal of public health 2007. PMID: 17267719


  246. Dickersin K, Straus SE, Bero LA. Evidence based medicine: increasing, not dictating, choice. BMJ (Clinical research ed.) 2007. PMID: 17204750


  247. Boyd EA, Bero LA. Improving the use of research evidence in guideline development: 4. Managing conflicts of interests. Health research policy and systems 2006. PMID: 17140441


  248. Steinman MA, Bero LA, Chren MM, Landefeld CS. Narrative review: the promotion of gabapentin: an analysis of internal industry documents. Annals of internal medicine 2006. PMID: 16908919


  249. Nguyen NT, Cook DM, Bero LA. The decision-making process of US Food and Drug Administration advisory committees on switches from prescription to over-the-counter status: a comparative case study. Clinical therapeutics 2006. PMID: 16982301


  250. Hong MK, Bero LA. Tobacco industry sponsorship of a book and conflict of interest. Addiction (Abingdon, England) 2006. PMID: 16869850


  251. Lopipero P, Bero LA. Tobacco interests or the public interest: 20 years of industry strategies to undermine airline smoking restrictions. Tobacco control 2006. PMID: 16885582


  252. Lee KP, Boyd EA, Holroyd-Leduc JM, Bacchetti P, Bero LA. Predictors of publication: characteristics of submitted manuscripts associated with acceptance at major biomedical journals. The Medical journal of Australia 2006. PMID: 16803442


  253. Cook DM, Bero LA. Identifying carcinogens: the tobacco industry and regulatory politics in the United States. International journal of health services : planning, administration, evaluation 2006. PMID: 17175844


  254. Glaser BE, Bero LA. Attitudes of academic and clinical researchers toward financial ties in research: a systematic review. Science and engineering ethics 2005. PMID: 16279755


  255. Cook DM, Tong EK, Glantz SA, Bero LA. The power of paperwork: how Philip Morris neutralized the medical code for secondhand smoke. Volume 24 of Issue 4. Health affairs (Project Hope) 2005. PMID: 16136637


  256. Bero LA, Glantz S, Hong MK. The limits of competing interest disclosures. Tobacco control 2005. PMID: 15791022


  257. Bero LA. Tobacco industry manipulation of research. Public health reports (Washington, D.C. : 1974) 2005. PMID: 15842123


  258. Baba A, Cook DM, McGarity TO, Bero LA. Legislating "sound science": the role of the tobacco industry. American journal of public health 2005. PMID: 16030333


  259. Bero LA. Managing financial conflicts of interest in research. The Journal of the American College of Dentists 2005. PMID: 16353375


  260. Dunsby J, Bero L. A nicotine delivery device without the nicotine? Tobacco industry development of low nicotine cigarettes. Tobacco control 2004. PMID: 15564619


  261. Lipton S, Boyd EA, Bero LA. Conflicts of interest in academic research: policies, processes, and attitudes. Accountability in research 2004. PMID: 15675050


  262. Boyd EA, Lipton S, Bero LA. Implementation of financial disclosure policies to manage conflicts of interest. Health affairs (Project Hope) 2004. PMID: 15046145


  263. White J, Bero LA. Public health under attack: the American Stop Smoking Intervention Study (ASSIST) and the tobacco industry. American journal of public health 2004. PMID: 14759933


  264. Michel MC, Bero LA, Bright T. Creating a text data-mining application for use in public health informatics. Conference proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual Conference 2004. PMID: 17270964


  265. Finley PR, Rens HR, Pont JT, Gess SL, Louie C, Bull SA, Lee JY, Bero LA. Impact of a collaborative care model on depression in a primary care setting: a randomized controlled trial. Pharmacotherapy 2003. PMID: 14524649


  266. Malone RE, Bero LA. Chasing the dollar: why scientists should decline tobacco industry funding. Journal of epidemiology and community health 2003. PMID: 12883046


  267. Boyd EA, Cho MK, Bero LA. Financial conflict-of-interest policies in clinical research: issues for clinical investigators. Academic medicine : journal of the Association of American Medical Colleges 2003. PMID: 12915362


  268. Grimshaw J, McAuley LM, Bero LA, Grilli R, Oxman AD, Ramsay C, Vale L, Zwarenstein M. Systematic reviews of the effectiveness of quality improvement strategies and programmes. Quality & safety in health care 2003. PMID: 12897365


  269. Lexchin J, Bero LA, Djulbegovic B, Clark O. Pharmaceutical industry sponsorship and research outcome and quality: systematic review. BMJ (Clinical research ed.) 2003. PMID: 12775614


  270. Bryan-Jones K, Bero LA. Tobacco industry efforts to defeat the occupational safety and health administration indoor air quality rule. American journal of public health 2003. PMID: 12660202


  271. Roth AL, Dunsby J, Bero LA. Framing processes in public commentary on US federal tobacco control regulation. Social studies of science 2003. PMID: 12918520


  272. Hong MK, Bero LA. How the tobacco industry responded to an influential study of the health effects of secondhand smoke. BMJ (Clinical research ed.) 2002. PMID: 12480862


  273. Beney J, Devine EB, Chow V, Ignoffo RJ, Mitsunaga L, Shahkarami M, McMillan A, Bero LA. Effect of telephone follow-up on the physical well-being dimension of quality of life in patients with cancer. Pharmacotherapy 2002. PMID: 12389880


  274. Finley PR, Rens HR, Pont JT, Gess SL, Louie C, Bull SA, Bero LA. Impact of a collaborative pharmacy practice model on the treatment of depression in primary care. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 2002. PMID: 12185826


  275. Shamasunder B, Bero L. Financial ties and conflicts of interest between pharmaceutical and tobacco companies. JAMA 2002. PMID: 12169078


  276. Lee KP, Schotland M, Bacchetti P, Bero LA. Association of journal quality indicators with methodological quality of clinical research articles. JAMA 2002. PMID: 12038918


  277. Rochon PA, Bero LA, Bay AM, Gold JL, Dergal JM, Binns MA, Streiner DL, Gurwitz JH. Comparison of review articles published in peer-reviewed and throwaway journals. JAMA 2002. PMID: 12038932


  278. Mowatt G, Shirran L, Grimshaw JM, Rennie D, Flanagin A, Yank V, MacLennan G, Gøtzsche PC, Bero LA. Prevalence of honorary and ghost authorship in Cochrane reviews. JAMA 2002. PMID: 12038907


  279. Montini T, Mangurian C, Bero LA. Assessing the evidence submitted in the development of a workplace smoking regulation: the case of Maryland. Volume 117 of Issue 3. Public health reports (Washington, D.C. : 1974) 2002. PMID: 12432140


  280. Malone RE, Wenger LD, Bero LA. High school journalists' perspectives on tobacco. Journal of health communication 2002. PMID: 12049422


  281. Ober M, Shohara R, Rennie D, Yank V, Bero LA. The Criticism Management System for the Cochrane Library. Evaluation & the health professions 2002. PMID: 11868449


  282. Schotland MS, Bero LA. Evaluating public commentary and scientific evidence submitted in the development of a risk assessment. Risk analysis : an official publication of the Society for Risk Analysis 2002. PMID: 12017355


  283. Bero LA, Montini T, Bryan-Jones K, Mangurian C. Science in regulatory policy making: case studies in the development of workplace smoking restrictions. Volume 10 of Issue 4. Tobacco control 2001. PMID: 11740023


  284. Bero L. Implications of the tobacco industry documents for public health and policy. Annual review of public health 2001. PMID: 12415145


  285. Wenger LD, Malone RE, George A, Bero LA. Cigar magazines: using tobacco to sell a lifestyle. Tobacco control 2001. PMID: 11544394


  286. Montini T, Bero LA. Policy makers' perspectives on tobacco control advocates' roles in regulation development. Tobacco control 2001. PMID: 11544384


  287. Grimshaw JM, Shirran L, Thomas R, Mowatt G, Fraser C, Bero L, Grilli R, Harvey E, Oxman A, O'Brien MA. Changing provider behavior: an overview of systematic reviews of interventions. Medical care 2001. PMID: 11583120


  288. Shojania KG, Bero LA. Taking advantage of the explosion of systematic reviews: an efficient MEDLINE search strategy. Effective clinical practice : ECP 2001. PMID: 11525102


  289. Bero LA. "Educational" advertisements--I haven't seen one yet! The Western journal of medicine 2001. PMID: 11381005


  290. Wenger L, Malone R, Bero L. The cigar revival and the popular press: a content analysis, 1987-1997. American journal of public health 2001. PMID: 11211641


  291. Mangurian CV, Bero LA. Lessons learned from the tobacco industry's efforts to prevent the passage of a workplace smoking regulation. Volume 90 of Issue 12. American journal of public health 2000. PMID: 11111269


  292. Anderson J, Baum M, Bero LA, Chalmers I, Chapman S, Deary IJ, Ebrahim S, Evans M, Farrell M, Greaves D, Higginson I, Hippisley-Cox J, James B, McKenzie H, Macaulay AC, Rabow M, Smyth RL, Stores G, Wolpert L. Music to be born to, music to die to. BMJ (Clinical research ed.) 2000. PMID: 11124186


  293. Boyd EA, Bero LA. Assessing faculty financial relationships with industry: A case study. JAMA 2000. PMID: 11056592


  294. Moynihan R, Bero L, Ross-Degnan D, Henry D, Lee K, Watkins J, Mah C, Soumerai SB. Coverage by the news media of the benefits and risks of medications. The New England journal of medicine 2000. PMID: 10833211


  295. Malone RE, Bero LA. Cigars, youth, and the Internet link. American journal of public health 2000. PMID: 10800432


  296. Beney J, Bero LA, Bond C. Expanding the roles of outpatient pharmacists: effects on health services utilisation, costs, and patient outcomes. The Cochrane database of systematic reviews 2000. PMID: 10908471


  297. Bero LA, Mays NB, Barjesteh K, Bond C. Expanding the roles of outpatient pharmacists: effects on health services utilisation, costs, and patient outcomes. The Cochrane database of systematic reviews 2000. PMID: 10796529


  298. Freemantle N, Harvey EL, Wolf F, Grimshaw JM, Grilli R, Bero LA. Printed educational materials: effects on professional practice and health care outcomes. The Cochrane database of systematic reviews 2000. PMID: 10796502


  299. Bero LA. Accepting commercial sponsorship. Disclosure helps--but is not a panacea. BMJ (Clinical research ed.) 1999. PMID: 10480803


  300. Kennedy GE, Bero LA. Print media coverage of research on passive smoking. Tobacco control 1999. PMID: 10599568


Publications results limited to 300 items. See the full profile on profiles.ucsf.edu.